We report a Burkitt's type lymphoblastic lymphoma (B-LL) case characterized by an abnormal IgMk immunoglobulin secretion and referred to us on February 12, 1982. The diagnosis has been histologically documented and the pathological stage of the disease (IV B) was determined according to the diagnostic criteria usually employed for the non-Hodgkin's lymphoma (NHL). Serum proteins were determined by electrophoresis and immunodiffusion. The review of the literature has allowed us to ascertain that the presence of a monoclonal IgM peak can be associated with NHL, particularly with those of B cell type and in adult subjects. Up to now, only six IgM B-LL secreting cases have been described. The biological and prognostic significance of this elevated Ig secretion is uncertain; therefore it may be important for the future to evaluate, in B-LL this immunological parameter.
Get full access to this article
View all access options for this article.
References
1.
AlexanianR.: Monoclonal gammopathy in lymphoma.Arch. Intern. Med., 135: 62–66, 1975.
2.
AxelssonV., BochmannR., HallenJ.: Frequency of pathological proteins (M-components) in 6,995 sera from adult population.Acta Med. Scand., 179: 235–247, 1966.
3.
Ben BassatJ., FlumanN., ZlotnickA.: Monoclonal immunoglobulin disorders: A report of 154 cases.Am. J. Med. Sci., 271: 325–334, 1976.
4.
BraunsteinA.H., KerenD.F.: Monoclonal gammopathy (IgM-k) in a patient with Burkitt's lymphoma.Arch. Pathol. Lab. Med., 107: 235–238, 1983.
5.
Caligaris CappioF., FoàR., BerguiL., CampanaD., FierroM.T., DeliaD., GobbiM., JanossyG.: Phorbol-ester-induced phenotypic modulation of B-chronic lymphocytic leukemia cells. In: Frontiers in Experimental Haematology V. 4. pp. 305–308. (Ed.) TorelliU., Serono Symposia, Milano, 1983.
6.
CawleyL.P., SchenkenJ.R.: Monoclonal hyper-gammaglobulinemia of the IgM type in a 9-year-old girl with ataxia-telangiectasia.Am. J. Clin. Pathol., 54: 790–801, 1970.
7.
De VitaV.T.Jr., HellmanS.: Hodgkin's disease and the non-Hodgkin's lymphomas. In: Cancer Principles and Practice of Oncology. (Ed.) De VitaV.T.Jr., HellmanS., RosenbergS.A., pp. 1331–1401. J.B. Lippincott Comp., Philadelphia, 1982.
8.
FineJ.M., LambinP.: Distribution of heavy chain classes and light chain types in 757 cases of monoclonal gammopathies.Biomedicine, 23: 323–327, 1975.
9.
FisherR.I., De VitaV.T.Jr., HubbardS.M., LongoD.L., WesleyR., ChabnerB.A., YoungR.C.: Diffuse aggressive lymphomas: Increased survival after alternating flexible sequences of ProMACE and MOPP chemotherapy.Ann. Intern. Med., 98: 304–309, 1983.
10.
GordonJ., MellstedtH., AmanP., BiberfeldP., BjorkholmM., KleinG.: Phenotypes in chronic-B-lymphocytic leukemia probeb by monoclonal antibodies and immunoglobulin secretion studies: Identification of stages of maturation arrest and the relation to clinical findings.Blood, 62: 910–917, 1983.
Preud'hommeJ.L., BrouetJ.C., DanonF.: Acute lymphoblastic leukemia with Burkitt's lymphoma cells.Membrane markers and serum immunoglobulin. J. Natl. Cancer Inst., 66: 261–264, 1981.
20.
ReedM., McKennaR.W., BridgesR.: Morphologic manifestations of monoclonal gammopathies.Am. J. Clin. Pathol., 76: 8–23, 1981.
21.
RubarstelliA., SitiaR., ZiccaA., GrassiC.E., FerrariniM.: Differentiation of chronic lymphocytic leukemia cells: correlation between the synthesis and secretion in immunoglobulins and the ultrastructure of the malignant cells.Blood, 62: 495–504, 1983.
22.
SalmonS.E.: Immunoglobulin synthesis and tumor kinetics of multiple myeloma.Sem. Hematol., 10: 135–147, 1973.
23.
SeligmanM., VoglerL.B., GuglielmiP., Preud'hommeJ.L., BrovetJ.C.: Leukemic cell markers in acute lymphoblastic leukemias of the B cell lineage and in chronic lymphocytic leukemias. In: Leukemia Markers, (Ed.) KnappW., pp. 437–451. Academic Press, London, 1981.
24.
StoopJ.W., ZegersB.J., Van Der HeidenC.: Monoclonal gammopathy in a child with leukemia.Blood, 32: 774–786, 1968.
